| | Class 2 Device Recall TVS LPA |  |
| Date Initiated by Firm | May 02, 2018 |
| Create Date | July 27, 2018 |
| Recall Status1 |
Terminated 3 on July 20, 2020 |
| Recall Number | Z-2561-2018 |
| Recall Event ID |
80021 |
| 510(K)Number | K000737 K172487 |
| Product Classification |
Cadiovascular, Introducer catheter - Product Code DRE
|
| Product | 1) TVS LPA, Sterile EO, Rx Only, Catalog #: a) KIT-071-01; b) KIT-071-03; c) KIT-071-10; d) KIT-071-11;
2) Enhance Transcarotid/Peripheral Access Kit, Sterile EO, Rx Only, Catalog #: a) KIT-075-02; b) KIT-075-03 |
| Code Information |
Lot #: 1) a) G18046082, G18046083, G18046084, G18046085; b) G18031106, G18031199, G18046076; c) G18030048, G18030049; d) G18030050, G18030204; 2) a) G18003035, G18101170; b) G18003036, G18003037, G18003038 |
Recalling Firm/ Manufacturer |
Galt Medical Corporation 2220 Merritt Dr Garland TX 75041-6137
|
| For Additional Information Contact | David Derrick 214-778-1306 |
Manufacturer Reason for Recall | The products listed might contain unsafe levels of bacterial endotoxins (Pyrogens) that were introduced during a manufacturing step. Bacterial Endotoxins also called pyrogenic bacteria can activate the inflammatory process and produce fever, chills, and hypotension in a patient. |
FDA Determined Cause 2 | Other |
| Action | On approximately 05/01/2018 recall letters and customer response forms were mailed to all consignees. |
| Quantity in Commerce | 8350 |
| Distribution | U.S.: MN, PA, VA, CA, UT, FL, NY, GA, LA, MO, TX, MS, OH, WA, MA, IL, KY, NC, and Puerto Rico;
OUS: Canada, Australia, France, Germany, Ireland, Italy, Netherlands, Poland, Slovakia, Switzerland, Belgium, United Kingdom, Korea |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
| 510(K) Database | 510(K)s with Product Code = DRE 510(K)s with Product Code = DRE
|
|
|
|